MET and neoplasm: Further exploration of the HGF/Met signaling pathway’s involvement in this interplay is crucial for elucidating the intricate mechanisms of tumor biology and laying the groundwork for novel therapeutic approaches to enhance the effectiveness of immunotherapy and the outcomes of cancer patients.